Objectives: The study aims to generate an immunological age (IA) trait on the basis of immune cell differentiation parameters, and to test whether the IA is related to age and disease characteristics.
| INTRODUCTION
In the recent years, the immune system has received increased attention in the study of the pathophysiology of mood disorders, especially inflammatory changes in bipolar disorder (BD). There is a welldescribed relationship between BD and general medical comorbidities with an inflammatory component, such as autoimmunity, heart diseases, respiratory diseases, type 2 diabetes, and the metabolic syndrome (Kilbourne et al., 2004; Osby, Brandt, Correia, Ekbom, & Sparen, 2001) , and new findings have emerged elucidating the cross talk between the brain and the immune system that may mediate these associations (Soczynska, Kennedy et al. 2011) . Among the most relevant, it is the discovery of bidirectional pathways connecting the nervous and immune systems (e.g., indoleamine 2,3-dioxygenase activation, the vagal reflex, active transport of cytokines across the blood-brain barrier, and others; Raison, Capuron, & Miller, 2006) . Several molecular and cellular immune abnormalities have been documented in BD, with elevated levels of proinflammatory cytokines demonstrated more prominently during mood episodes, especially those of manic polarity (Brietzke et al., 2009) . Euthymic patients also show differences when compared with healthy volunteers (Modabbernia, Taslimi, Brietzke, & Ashrafi, 2013) . Changes in the proportions of different cellular subsets, such as increased circulating monocytes and activated cells, and decreased regulatory T cells have been reported; as have changes in pathways downstream of immune cell signaling such as increased phosphorylation of NFκB and ERK proteins, and decreased sensitivity to glucocorticoids) (Breunis et al., 2003; do Prado et al., 2013; Wieck et al., 2013) .
Similarities between immune abnormalities in BD and the continuous shaping of immune characteristics during natural aging, termed immunosenescence, have been noted (Maurya et al., 2016; Rizzo et al., 2014; SayuriYamagata, Brietzke, Rosenblat, Kakar, & McIntyre, 2017) .
Immunosenescence affects both innate and adaptive arms of immunity, with reduced production of B and T cells in bone marrow and the thymus, and diminished function of mature lymphocytes in secondary lymphoid tissues. As a result, elderly individuals respond less robustly to immune challenge than the young (Montecino-Rodriguez, BerentMaoz, & Dorshkind, 2013), but they are prone to chronic low-grade inflammatory activity, described collectively by some researchers as "inflammaging" (Baylis, Bartlett, Patel, & Roberts, 2013) .
From these markers, it might be reasonable to assume an underlying factor, "immunological age" (IA), and useful to use this factor to estimate the extent of immunosenescence in BD. Specifically, immunosenescence has been associated with an increased proportion of late-differentiated T (e.g., CD3+CD8+CD28-CD27-; Aiello et al., 2016 ) and B cells (e.g., CD3-CD19+IgD-CD27-; 14), a reduced proportion of activated T cells after stimulation (i.e., reduced expression of CD69 and CD71 proteins on the T cell surface; Lio et al., 1996) and with decreased regulatory T (Treg) cell suppressive capacity, partially due to decreased expression of CD152 (Tsaknaridis et al., 2003) .
Therefore, we hypothesize that a latent trait for IA would be related positively to CD3+CD8+CD28-CD27-and CD3-CD19+IgD-CD27-cells, and negatively to cells bearing CD69, CD71, and CD152. We consider that this latent measure (i.e., IA) might be correlated with clinical features of the disorder, and with patient outcomes.
The main objective of this work was to provide evidence of a measurement model for IA on the basis of five putative cellular and molecular parameters obtained by flow cytometry. Underlying the observed indicators, we hypothesize a single IA factor. Evidence of convergent validity with chronological age was also sought. To probe the potential for clinical relevance, the IA was compared with characteristics of the course of BD type I between participants, including the number of previous mood episodes.
| MATERIALS AND METHODS

| Sample
The sample consisted of 44 male and female euthymic patients with BD type I, aged 18 to 65 years, attending a regular follow-up in a secondary outpatient clinic. Psychiatric diagnosis was based on clinical interview and confirmed with the Structured Clinical Interview for
DSM-IV-Axis I (SCID-I). Manic and depressive symptoms severities
were assessed using the Young Mania Rating Scale and the Hamilton Depression Rating Scale-17 items, respectively. To be included euthymic, patients did not fulfill DSM-IV criteria for any current mood episode and they presented with Young Mania Rating Scale and Hamilton Depression Rating Scale below 8. All the patients were under a stable medication treatment regimen (taking the same medications in the same doses for a minimum of 2 months prior to the study inclusion). Exclusion criteria were: (a) recent use of anti-inflammatories (up to and including the previous 2 weeks); (b) treatment with immunomodulatory drugs; and (c) acute of chronic general medical condition associated with imbalances in immune-inflammatory pathways, such as infections, HIV infection, allergies, and autoimmune diseases (e.g., rheumatoid arthritis and inflammatory bowel disease). In addition, women were excluded if they were pregnant or postpartum.
| Blood collection and cell isolation
A sample of 15 ml of peripheral blood was obtained from each subject by arm venipuncture. The blood collection was made in a standardized time of day (between 08:00 and 10:00 a.m.) and following a 12-hr period of fasting. Peripheral blood mononuclear cells (PBMCs) were isolated from BD Vacutainer® EDTA tubes by density gradient centrifugation for 30 min at 900×g (Ficoll® Paque Plus, GE Healthcare Life Sciences, SP, Brazil). Cells were counted by means of microscopy, and viability confirmed to exceed 95%, as judged from their ability to exclude Trypan Blue (Sigma).
| Flow cytometry
To examine lymphocyte subsets, 2 × 10 5 PBMCs were stained directly for 30 min with combinations of anti-CD3 FITC, -CD4 APCCy7, -CD8
APCCy7, -IgD BV42, -CD25 BV510, and -CD152 PECy5 monoclonal antibodies (BD Biosciences). For intracellular FoxP3 staining, the Human FoxP3 Buffer Set (BD Biosciences) was used after surface staining, including cell fixation, permeabilization, and staining with the monoclonal antibody anti-FoxP3 Alexa647.
An additional aliquot of PBMCs were stimulated in 96-well plates coated with 5 μg/ml anti-human CD3 antibody (OKT3, eBioscience) (previously prepared, overnight at 4°C). The PBMCs (1 x 10 5 cells)
were added to each well with antihuman CD28 antibody (CD28.2, eBioscience) in a final concentration of 5 μg/ml. The PBMCs were cultivated in RPMI 1640 culture medium supplemented with L-glutamine, 10% fetal bovine serum, antibiotics, and antimycotics (Life-Thermo Fischer). The cells were allowed to grow for 3 days at 37°C in a 5%
CO 2 atmosphere after which time the T helper (Th) and T cytotoxic (Tc) activation markers CD69 and CD71 and the Treg functional molecule CD152 were counted and stained (as above).
Cells were analyzed by flow cytometry immediately after staining.
At least 50,000 lymphocytes were identified by size (forward scatter; FSC) and granularity (side scatter; SSC) and they were acquired with a FACSCantoII flow cytometer (BD Biosciences). Isotype controls for all fluorophores were used as negative controls. Data were analyzed using the FlowJo 7.2.5 software (Tree Star Inc.).
| Statistical analysis
Confirmatory factor analysis ( A CFA with covariates, also called "multiple-indicator, multiplecause" (MIMIC; B. O. Muthén, 1989) , was used to investigate invariance of the IA trait in relation to chronological age by allowing a direct path from age to each observed variable. MIMIC is a flexible way of invariance testing at the indicator level (Finch, 2005; Fleishman, Spector, & Altman, 2002) Lastly, to estimate a likely indirect effect of mood episodes on IA via BMI, we used a bias-corrected bootstrap confidence interval (Hayes, 2013) . The hypothesis of this indirect effect stems from observations that BMI increase during manic episodes (Fiedorowicz, Andersen, Persons, & Calarge, 2015) , which is path a. The second step in the mediation, path b, is based on the observation that BMI can be related to inflammatory markers in BD (Lee et al., 2013) . Moreover, this mediation model hypothesis was based on previous studies, which have found that obesity is associated with inflammation, and a metaanalysis (Howren, Lamkin, & Suls, 2009) suggested that this relationship was mediated in part by BMI. Therefore, we hypothesized that immunological changes in BD might similarly be related to BMI. Similarly, manic episodes were predicted by inflammation in a study of men with depressive symptoms (Becking et al., 2013 3 | RESULTS
| Sample characteristics
Descriptive statistics are shown in Table 1 (n = 44). The mean number of mood episodes was 5.93 (SD = 3.51) for any polarity, three for manic polarity (SD = 2.59), and 1.9 (SD = 2.13) for depressive polarity.
| Building and evaluating a unidimensional immunosenescence model
The correlation/covariance matrices for the unidimensional model with four indicators are reported in Table 2 
| Convergent validity and invariance of IA with chronological age
In a MIMIC model (Figure 2 ), no differential item functioning (i.e., no modification indices greater than 3.84) with respect to age was observed; the direct effects between age and the five cellular indicators (depicted by dashed lines) was not significant controlling for IA, therefore each cellular marker was functioning properly over the range of ages in the sample. There was a significant correlation between IA and chronological age (B = 0.03, β = 0.360, p = .013), suggesting that the IA has validity as an age-related phenomenon; the older the patient, the greater the IA values. Table 3 shows the correlation/covariance matrix for all the used variables for the subsequent analysis. In a path analysis controlling for age 4 | DISCUSSION Here we tested a measurement model for "immunological aging" factor informed by five cellular immunosenescence markers measured using flow cytometry. Using CFA, we obtained evidences for the construct and convergent validity of such measurement model which returned good fit indices (i.e., preconceived model adherence to the data and acceptability of the solution) and meaningful parameters estimates (i.e., substantive relation between the indicators and the IA and the latter with clinical features).
| Associations between IA and clinical characteristics
An association between the number of previous mood episodes and IA suggests that the IA may be clinically relevant and related to the course of the disorder. The observed association between IA and BMI would be consistent with the suggestion that metabolic dysfunction is related to immunosenescence in BD (Kilbourne et al., 2004; Osby et al., 2001; Yamagata et al., 2017) . Because BMI has also been related to chronicity, disability, and less likelihood of achieving complete remission with treatment (Galvez et al., 2014; C. Hu et al., 2017), IA might also be assessed as a prospective predictor of these outcomes in further studies (Calkin et al., 2009 ). Further, we offer evidence that higher BMI is responsible for the relationship between manic episodes and immunological aging. The finding is consistent with the previous prospective study suggesting that manic episodes represent high-risk periods for the accumulation of adiposity (Fiedorowicz et al., 2015) .
The observed indicator with the highest absolute contribution to the IA model was CD3+CD71+ (λ = −0.833, p < .001) known as transferrin receptor protein 1 (TfR1), an early/middle molecular marker in the process of cellular activation (Caruso et al., 1997) . Lio et al. (1996) showed that the expression of CD71 in T cells could be also used to follow their proliferative capacity. The lack of proper T cell proliferation is a well replicated finding of the immunosenescence process (Candore et al., 1992; Ferguson, Wikby, Maxson, Olsson, & Johansson, 1995; Potestio et al., 1998) . for binding to CD80 and CD86 in APCs, consequently impairing the immune response (Sakaguchi, Miyara, Costantino, & Hafler, 2010) .
Studies in mice and humans have reported a decrease in Treg suppressive capacity in the elderly (Tsaknaridis et al., 2003; Zhao et al., 2007) , which was partially explained by a decrease in CD152 expression (Tsaknaridis et al., 2003) . defined by the presence of moderate or severe Alzheimer's disease (Bulati et al., 2015; Martorana et al., 2014) , and decreased in a population with a genetic advantage for longevity (Martorana et al., 2014) . It is possible that this marker reflects specific pathological processes that are also more common with aging (e.g., Alzheimer's FIGURE 1 Confirmatory factor analysis of five (left) and four (right) immune markers. Markers related to an IA latent variable. Factor loadings of each marker are shown with their respective standard errors in parentheses. Four markers were found to have meaningful factor loadings, and they were used in the final model. IA = immunological aging FIGURE 2 Multiple-indicators, multiple-causes model evaluating invariance of the immunological aging trait with age. The biological markers did not function differently across different ages (i.e., no evidence of measurement invariance was found). Age was correlated with the IA trait. This indicates that the correlation between age and IA is a true correlation and not an artefact of differential item functioning. IA = immunological aging disease) rather than aging itself per se; however, our data cannot speak to this possible interpretation.
The CD3+CD8+CD28-CD27-cells have lost the expression of the CD28 and CD27 proteins, which are necessary for their complete stimulation and clonal expansion and maturation. These cells have short telomeres, impaired cytotoxic function, and they are resistant to apoptosis (Derhovanessian, Larbi, & Pawelec, 2009; Weng, Akbar, & Goronzy, 2009 ). The proportion of CD3+CD8+CD28-CD27-cells increases with aging and a high frequency in the elderly correlates with a less effective response to influenza virus vaccination (Goronzy et al., 2001 ) and with a higher risk of mortality (Olsson et al., 2000; Wikby et al., 2002). Fletcher and collaborators (2005) demonstrated that expansion of CD3+CD8+CD28-CD27-can be related to CMV infectious burden (Fletcher et al., 2005) . Human CMV has increasingly been implicated in accelerated immunosenescence in aging studies (Spyridopoulos et al., 2009) . It is usually present as a latent and asymptomatic infection, generating a permanent alert state of the immune system, leading to overwork of the immune system, and the observed changes in CD3+CD8+CD28-CD27-cell populations (Fulop, Larbi, & Pawelec, 2013) .
As potential limitations, the study was cross-sectional in design, necessitating further longitudinal studies and limiting our ability to comment on the utility of the IA trait as a predictive biomarker. As a relatively small study, inferences as to effects of covariates on the IA were limited, and estimates should be viewed as preliminary. In addition, examination of missing data (e.g., missingness mechanism and different approaches to deal with missing data [e.g., multiple imputation]) was not undertaken and results should be interpreted accordingly; the mediation model deals with missing values using a full information maximum likelihood estimator.
All subjects were assessed in euthymia and the majority was using medication, and therefore, the results may not generalize to BD patients in acute mania or depression, or to patients who are unmedicated; however, (Figures 1-4 ; n = 44) 
